WHO Pauses Hydroxychloroquine
Medical Trials for COVID-19 The move comes after a report linked the drug to an
increased fatality rate among those with coronavirus. The study in medical journal 'The..
Credit: Wibbitz Top Stories Duration: 01:30Published
Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe..
France Rejected hydroxychloroquine For Covid Patients
![WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 [Video]](https://video.newsserve.net/300/v/20200527/1307717686-WHO-Pauses-Hydroxychloroquine-Medical-Trials-for-COVID-19.jpg)
![France Becomes the First Country to Ban Hydroxychloroquine as a Treatment for COVID-19 [Video]](https://video.newsserve.net/300/v/20200527/1307716356-France-Becomes-the-First-Country-to-Ban-Hydroxychloroquine.jpg)
![Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug [Video]](https://video.newsserve.net/300/v/20200526/2005261936-Amid-HCQ-row-AIIMS-Director-explains-two-different.jpg)
